ZimVie Inc. (ZIMV)

Overall impact
A (82)

Commentary

ZimVie Inc. is a leader for overall positive impact. With an 'A' rating of 81.7 for overall impact (95th percentile compared to all companies), ZimVie Inc. ranks 10th out of 216 industry peers, behind Clario, Pediatrix Medical Group, COMPASS Pathways and 6 others, and ahead of US Neurosurgical, GeneDx Holdings Corp, FinThrive and 203 others. On top material causes for ZimVie Inc.'s industry (Health Care Providers & Services), ZimVie Inc. performs well in Quality Lifelong Education (95.2 score), Technology Innovation (80.1), Technology Innovation (80.1) and 37 other causes where it received an 'A' score and performs poorly in Humane Treatment of Animals (33.2 score) and Humane Treatment of Animals (33.2).
Impact
Cause ZIMV
Peer rank
Overall impact

Log in to view this information

Impact trend

Change in rating for overall impact

Log in to view this information

Company
Founded
2022
Employees
2,600
Sector
Health Care
Industry
Health Care Providers & Services
Sub-industry
Health Care Services
SASB industry
Health Care Delivery
Headquarters
United States
Share classes
ZIMV
More info
Description
ZimVie Inc is focused on the dental and spine markets and their respective growth drivers such as implants, surgical tools, bone graft substitutes, spinal fusion implants, non-fusion alternatives, and digital care management solutions. Business is organized into two operating segments: the spine products segment and the dental products segment.
Material causes
Ethos considers the following causes material for ZimVie Inc., based on its industry sub-industry Health Care Services. Learn more about material causes in our methodology overview.

This information is subject to Ethos' Terms and Conditions, which you can find here.

This information may not be used for corporate financing purposes (including, without limitation, ESG-linked loans, credit facilities, securities or structured products), as a basis for any financial instruments or products (including, without limitation, passively managed funds and index-linked derivative securities) or other products or services, to verify or correct data in any other compilation of data or index, to create any derivative works, nor to create any other data or index (custom or otherwise), without Ethos' prior written permission.

By browsing this site you agree to our use of cookies. Read more.
We use cookies on this site to enhance your user experience. By continuing to browse the site, you are agreeing to our use of cookies. Give me more info.